STREPTOZOCIN PLUS FLUOROURACIL VERSUS DOXORUBICIN THERAPY FOR METASTATIC CARCINOID-TUMOR

[1] Cox D. R., 1989, BIOMETRICS, V32, DOI DOI 10.2307/2531476

[2] COX DR, 1972, J R STAT SOC B, V34, P18

[3] DAVIS Z, 1973, SURG GYNECOL OBSTET, V137, P637

[4] JOHNSON LA, 1983, CANCER-AM CANCER SOC, V51, P882, DOI 10.1002/1097-0142(19830301)51:5<882::AID-CNCR2820510522>3.0.CO

[5] 2-8

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[7] KESSINGER A, 1977, CANCER TREAT REP, V61, P101

[8] EFFECT OF MELPHALAN IN MALIGNANT CARCINOID SYNDROME [J]. ARCHIVES OF INTERNAL MEDICINE, 1969, 124 (01) : 36 - &

[9] MENGEL CE, 1965, CANCER CHEMOTHER REP, V51, P234

[10] Moertel C G, 1979, Cancer Clin Trials, V2, P327

[1] Cox D. R., 1989, BIOMETRICS, V32, DOI DOI 10.2307/2531476

[2] COX DR, 1972, J R STAT SOC B, V34, P18

[3] DAVIS Z, 1973, SURG GYNECOL OBSTET, V137, P637

[4] JOHNSON LA, 1983, CANCER-AM CANCER SOC, V51, P882, DOI 10.1002/1097-0142(19830301)51:5<882::AID-CNCR2820510522>3.0.CO

[5] 2-8

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[7] KESSINGER A, 1977, CANCER TREAT REP, V61, P101

[8] EFFECT OF MELPHALAN IN MALIGNANT CARCINOID SYNDROME [J]. ARCHIVES OF INTERNAL MEDICINE, 1969, 124 (01) : 36 - &

[9] MENGEL CE, 1965, CANCER CHEMOTHER REP, V51, P234

[10] Moertel C G, 1979, Cancer Clin Trials, V2, P327